-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XB-002 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XB-002 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XB-002 in Solid Tumor Drug Details: XB-002 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KITE-222 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KITE-222 in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KITE-222 in Mantle Cell Lymphoma Drug Details: KITE-222 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KITE-222 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KITE-222 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KITE-222 in Acute Lymphocytic Leukemia (ALL, Acute...
-
Product Insights
Primary Sjogren’s Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Primary Sjogren's Syndrome - Drugs In Development, 2023’, provides an overview of the Primary Sjogren's Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Primary Sjogren's Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Goiter – Drugs In Development, 2023
Global Markets Direct’s, ‘Goiter - Drugs In Development, 2023’, provides an overview of the Goiter pipeline landscape. The report provides comprehensive information on the therapeutics under development for Goiter, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Graves Diseases – Drugs In Development, 2023
Global Markets Direct’s, ‘Graves Diseases - Drugs In Development, 2023’, provides an overview of the Graves Diseases pipeline landscape. The report provides comprehensive information on the therapeutics under development for Graves Diseases, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Thyroid Gland Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Thyroid Gland Disorders - Drugs In Development, 2023’, provides an overview of the Thyroid Gland Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thyroid Gland Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Loncastuximab Tesirine in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Loncastuximab Tesirine in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Loncastuximab Tesirine in Follicular Lymphoma Drug Details: Loncastuximab Tesirine (Zynlonta) is a...
-
Product Insights
Sicca Syndrome (Sjogren) – Drugs In Development, 2023
Global Markets Direct’s, ‘Sicca Syndrome (Sjogren) - Drugs In Development, 2023’, provides an overview of the Sicca Syndrome (Sjogren) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Sicca Syndrome (Sjogren), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Anal Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Anal Cancer - Drugs In Development, 2023’, provides an overview of the Anal Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...